CN Patent

CN101031548A — N－(4－氟苄基)－n－(1－甲基哌啶－4－基)－n'－(4－(2－甲基丙氧基)－苯基甲基)脲的盐及其制备

Assigned to Acadia Pharmaceuticals Inc · Expires 2007-09-05 · 19y expired

What this patent protects

本发明公开了式(I)所示的N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲的盐，该盐包括柠檬酸盐、延胡索酸盐、马来酸盐、苹果酸盐、磷酸盐、琥珀酸盐、硫酸盐和乙二磺酸盐。

USPTO Abstract

本发明公开了式(I)所示的N－(4－氟苄基)－N－(1－甲基哌啶－4－基)－N’－(4－(2－甲基丙氧基)－苯基甲基)脲的盐，该盐包括柠檬酸盐、延胡索酸盐、马来酸盐、苹果酸盐、磷酸盐、琥珀酸盐、硫酸盐和乙二磺酸盐。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN101031548A
Jurisdiction: CN
Classification: —
Expires: 2007-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Acadia Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.